Pneumocystis Pneumonia in a Patient With Colorectal Cancer Receiving Bevacizumab and mFOLFOX6 Therapy
This case reaffirms that advanced age, immunosuppression, and cumulative steroid exposure are critical risk factors for PCP. Early imaging and prophylactic TMP-SMX administration should be considered in high-risk patients. Early intervention is crucial to prevent PCP progression to ARDS in patients with solid tumors.
Authors
- Naoyuki Nomura (ORCID: https://orcid.org/0000-0002-4499-6140)
- Terutaka Hamaoka
- Masatoshi Maki (ORCID: https://orcid.org/0000-0003-3898-3404)
- Ryo Takada (ORCID: https://orcid.org/0000-0002-7958-5819)
- Satoru Senoo (ORCID: https://orcid.org/0000-0001-7506-2247)
- Yuki Chiko
- Seiji Saito (ORCID: https://orcid.org/0000-0002-7433-9141)
- Yoko Takahashi
Institutions
- Okinawa Prefectural Yaeyama Hospital (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2025-05-03
- DOI
- https://doi.org/10.21873/cdp.10452
- Primary Topic
- Pneumocystis jirovecii pneumonia detection and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00